Authors:
DONELLI MG
ZUCCHETTI M
MUNZONE E
DINCALCI M
CROSIGNANI A
Citation: Mg. Donelli et al., PHARMACOKINETICS OF ANTICANCER AGENTS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION, European journal of cancer, 34(1), 1998, pp. 33-46
Authors:
SOTTANI C
MINOIA C
DINCALCI M
PAGANINI M
ZUCCHETTI M
Citation: C. Sottani et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY PROCEDURE WITH AUTOMATED SOLID-PHASE EXTRACTION SAMPLE PREPARATION FOR THE QUANTITATIVE-DETERMINATION OF PACLITAXEL (TAXOL(R)) IN HUMAN PLASMA, Rapid communications in mass spectrometry, 12(5), 1998, pp. 251-255
Authors:
ZUCCHETTI M
BOIARDI A
SILVANI A
PARISI I
PICCOLROVAZZI S
DINCALCI M
Citation: M. Zucchetti et al., DAUNORUBICIN AND DAUNORUBICINOL LEVELS IN HUMAN GLIOMA TUMORS AFTER ADMINISTRATION OF LIPOSOMAL ENCAPSULATED DAUNORUBICIN (DAUNOXOME), Annals of oncology, 9, 1998, pp. 617-617
Authors:
GHIELMINI M
COLLI E
BOSSHARD G
ZUCCHETTI M
DINCALCI M
GERONI C
SESSA C
Citation: M. Ghielmini et al., EVALUATION OF THE HEMATOTOXIC POTENTIAL OF METHOXYMORPHOLINYL-DOXORUBICIN (MMDX) METABOLITES IN PATIENTS PLASMA BY CLONOGENIC ASSAYS ON HEMATOPOIETIC PROGENITOR CELLS, Annals of oncology, 9, 1998, pp. 206-206
Authors:
SESSA C
ZUCCHETTI M
BAUER J
NAEGELE H
DINCALCI M
GHIELMINI M
ROSSI S
VANDENBULCKE T
PACCIARINI M
DOMENIGONI L
CAVALLI F
Citation: C. Sessa et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ORAL (PO) METHOXY-MORPHOLINO DOXORUBICIN (PNU-152243) ON A SINGLE INTERMITTENT SCHEDULE, Annals of oncology, 9, 1998, pp. 450-450
Authors:
BRODEN K
EDWARDS R
LINDBERG M
ROCCO P
ZUCCHETTI M
Citation: K. Broden et al., WASTE FROM FUSION-REACTOR - A COMPARISON WITH OTHER ENERGY PRODUCING SYSTEMS, Fusion engineering and design, 42, 1998, pp. 1-6
Authors:
BASSAN R
CHIODINI B
ZUCCHETTI M
LEREDE T
CORNELLI PE
CORTELAZZO S
BARBUI J
Citation: R. Bassan et al., SHORT-COURSE INFUSIONAL IDARUBICIN PLUS INTERMITTENT CYTARABINE AND ETOPOSIDE FOR REFRACTORY HEMATOLOGIC MALIGNANCIES - CLINICAL AND PRELIMINARY PHARMACOLOGICAL RESULTS, Haematologica, 83(1), 1998, pp. 27-33
Authors:
CORSINI C
MANCUSO P
GHIELMINI M
ZUCCHETTI M
TEALDO F
COCOROCCHIO E
FERRUCCI PF
PECCATORI F
DINCALCI M
MARTINELLI G
Citation: C. Corsini et al., INHIBITION OF CFU-GM GROWTH BY IDARUBICINOL CONTAINING PLASMA SAMPLESOBTAINED FROM POOR-PROGNOSIS LYMPHOMA PATIENTS TREATED WITH 3-DAYS INFUSION IDARUBICIN, Experimental hematology, 26(8), 1998, pp. 378-378
Authors:
MORAZZONI F
CANEVALI C
ZUCCHETTI M
CAROLI S
ALIMONTI A
PETRUCCI F
GIUDICE G
MASONI E
BEDINI AV
Citation: F. Morazzoni et al., CIS-DIAMMINEDICHLOROPLATINUM(II) GIVEN IN LOW-DOSE CONTINUOUS-INFUSION WITH CONCURRENT RADIOTHERAPY TO PATIENTS AFFECTED BY INOPERABLE LUNG-CARCINOMA - A PHARMACOKINETIC APPROACH, Journal of cancer research and clinical oncology, 124(1), 1998, pp. 37-43
Authors:
SOTTANI C
MINOIA C
COLOMBO A
ZUCCHETTI M
DINCALCI M
FANELLI R
Citation: C. Sottani et al., STRUCTURAL CHARACTERIZATION OF MONOHYDROXYLATED AND DIHYDROXYLATED METABOLITES OF PACLITAXEL IN RAT BILE USING LIQUID-CHROMATOGRAPHY ION-SPRAY TANDEM MASS-SPECTROMETRY, Rapid communications in mass spectrometry, 11(9), 1997, pp. 1025-1032
Authors:
SOTTANI C
MINOIA C
COLOMBO T
ZUCCHETTI M
DINCALCI M
FANELLI R
Citation: C. Sottani et al., STRUCTURE ELUCIDATION OF TAXOL METABOLITES BY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY AND SPECIES-DIFFERENCES IN TAXOL METABOLISM - REPLY, Rapid communications in mass spectrometry, 11(16), 1997, pp. 1824-1824
Authors:
COLOMBO T
PAZ OG
ZUCCHETTI M
MANEO M
SESSA C
GOLDHIRSCH A
DINCALCI M
Citation: T. Colombo et al., PACLITAXEL INDUCES SIGNIFICANT CHANGES IN EPIDOXORUBICIN DISTRIBUTIONIN MICE (VOL 7, PG 801, 1996), Annals of oncology, 8(2), 1997, pp. 207-207
Authors:
BRODEN K
LINDBERG M
NISAN S
ROCCO P
ZUCCHETTI M
TAYLOR N
FORTY C
Citation: K. Broden et al., MANAGEMENT OF WASTE FROM THE INTERNATIONAL-THERMONUCLEAR-EXPERIMENTAL-REACTOR AND FROM FUTURE FUSION-POWER-PLANTS, Fusion engineering and design, 36(1), 1997, pp. 49-56
Citation: P. Rocco et M. Zucchetti, MANAGEMENT STRATEGY TO REDUCE THE RADIOACTIVE-WASTE AMOUNT IN FUSION, Journal of fusion energy, 16(1-2), 1997, pp. 141-148
Authors:
PECCATORI F
COCOROCCHIO E
MUNZONE E
CORSINI C
ZUCCHETTI M
FERRUCCI PF
CINIERI S
DINCALCI M
MARTINELLI G
Citation: F. Peccatori et al., IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION, Blood, 90(10), 1997, pp. 4381-4381
Authors:
GENTILI D
CONTER V
RIZZARI C
TSCHUEMPERLIN B
ZUCCHETTI M
ORLANDONI D
DINCALCI M
MASERA G
Citation: D. Gentili et al., L-ASPARAGINE DEPLETION IN PLASMA AND CEREBROSPINAL-FLUID OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA DURING SUBSEQUENT EXPOSURES TO ERWINIA L-ASPARAGINASE, Annals of oncology, 7(7), 1996, pp. 725-730
Authors:
CARPIGNANO A
FRANCABANDIERA S
VELLA R
ZUCCHETTI M
Citation: A. Carpignano et al., ENVIRONMENTAL-IMPACT ANALYSIS FOR THE MAIN ACCIDENTAL SEQUENCES OF IGNITER, Fusion technology, 30(3), 1996, pp. 1490-1494
Authors:
PAGANI O
ZUCCHETTI M
SESSA C
DEJONG J
DINCALCI M
DEFUSCO M
KAESERFROHLICH A
HANAUSKE A
CAVALLI F
Citation: O. Pagani et al., CLINICAL AND PHARMACOKINETIC STUDY OF ORAL NK611, A NEW PODAPHYLLATOXIN DERIVATIVE, Cancer chemotherapy and pharmacology, 38(6), 1996, pp. 541-547